- 2025-04-12 17:38Erythromycin C 1675-02-1
- 2025-04-12 17:38Anti-parasitic agent 3 2366983-10-8
- 2025-04-12 17:38TG-101209 936091-14-4
- 2025-04-12 17:38HBV-IN-49 380458-45-7
- 2025-04-12 17:38Fusion Inhibitory Peptide (ZD-Phe-Phe-Gly-OH; FIP; Virus Replication Inhibitory Peptide) 75539-79-6
- 2025-04-12 17:38Monodes(N-carboxymethyl)valine Daclatasvir (Daclatasvir Impurity A) 1007884-60-7
- 2025-04-12 17:38Estradiol valerate (β-estradiol 17-valerate) 979-32-8
- 2025-04-12 17:38CDD-1733 2894104-33-5
- 2025-04-12 17:38VEGFR-2-IN-5 hydrochloride 2700435-52-3
- 2025-04-12 17:38DDX3-IN-2 1919828-81-1
- 2025-04-12 17:38Glucocorticoid receptor agonist-5 2913231-72-6
- 2025-04-12 17:38GGFG-PAB-Exatecan 251459-32-2
- 2025-04-12 17:38LCZ696 (Sacubitril-Valsartan) 936623-90-4
- 2025-04-12 17:3812-HETE (12-hydroxyeicosatetraenoic acid) 71030-37-0
- 2025-04-12 17:38EGFR-IN-124
- 2025-04-12 17:38AZD4320 1357576-48-7
- 2025-04-12 17:38Fluparoxan 105182-45-4
- 2025-04-12 17:38EBOV-IN-10 3040400-51-6
- 2025-04-12 17:38Anti-inflammatory agent 40
- 2025-04-12 17:38Ac-VDVAD-pNA 189684-53-5
